Introduction
Introduction Statistics Contact Development Disclaimer Help
Multiparameter Flow Cytometry to Detect Hematogones and to Assess B...
by:
Carulli, Giovanni
Ottaviano, Virginia
Guerri, Valentina
Giuntini, Stefano
Sammuri, Paola
Ciancia, Eugenio M.
Azzara, Antonio
Thumbnail
Download
Web page
This article is from Hematology Reports[1], volume 6[2].
Abstract
Hematogones are precursors of B-lymphocytes detected in
small numbers in the bone marrow. Flow cytometry is the
most useful tool to identify hematogones and, so far, 4-
color methods have been published. In addition, flow
cytometry is used in the diagnosis and follow-up of
lymphomas. We developed a flow cytometric 7-color method
to enumerate hematogones and to assess B-lymphocyte
clonality for routine purposes. We evaluated 171 cases of
B-cell non-Hodgkin lymphomas, either at diagnosis or in
the course of follow-up. By our diagnostic method, which
was carried out by the combination K/
/CD20/CD19/CD10/CD45/CD5, we were able to detect
hematogones in 97.6% of samples and to distinguish normal
B-lymphocytes, neoplastic lymphocytes and hematogones in
a single step. The percentage of hematogones showed a
significant inverse correlation with the degree of
neoplastic infiltration and, when bone marrow samples not
involved by disease were taken into consideration,
resulted higher in patients during follow-up than in
patients evaluated at diagnosis.
References
1. //archive.org/search.php?query=journaltitle%3A%28Hematology%20Reports%29 (l…
2. //archive.org/search.php?query=journaltitle%3A%28Hematology%20Reports%29%20…
Date Published: 2014-10-17 00:33:41
Identifier: pubmed-PMC4091289
Item Size: 12685765
Language: eng
Media Type: texts
# Collections
pubmed
journals
# Uploaded by
@jakej
# Similar Items
View similar items
PHAROS
You are viewing proxied material from tilde.pink. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.